Hence, at the silver jubilee of tPA in managing AIS patients, we are prompted to look into the 25 years of evolution of the tPA therapeutic window, and at its promising future directions, all of which are summarized below. The gene discussed is PLAT; the disease is androgen insensitivity syndrome.